| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review articles |
Department of Medicine and Obstetrics/Gynaecology, University of Ottawa, Ottawa Hospital, Ottawa, ON, Canada
Correspondence to: Erin Keely, Department of Medicine and Obstetrics/Gynaecology, University of Ottawa, Ottawa Hospital, Riverside Campus Box 215, 1967 Riverside Door, Ottawa, ON, Canada K1H 7W9 Email: ekeely{at}ottawahospital.on.ca
Women with Type 2 diabetes (T2DM) are an increasingly important part of the practice of obstetric medicine. The rising rates of obesity and advanced maternal age have resulted in a surge in the number of pregnant women with T2DM. The hyperglycaemia and associated conditions of the metabolic syndrome lead to poor obstetric outcome and impact on the long-term health of the mother and offspring. It is essential that women and care-givers recognize the seriousness of T2DM in pregnancy and strive to improve prepregnancy care, obstetric outcome and the long-term health of both the mother and child.
Key Words: diabetes prepregnancy glycaemic control
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?